SGCA
Steel Grove Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,572
| Closed | -$290K | – | 188 |
|
|
2025
Q1 | $290K | Sell |
3,572
-2,400
| -40% | -$195K | 0.04% | 137 |
|
|
2024
Q4 | $538K | Sell |
5,972
-750
| -11% | -$67.5K | 0.07% | 104 |
|
|
2024
Q3 | $662K | Hold |
6,722
| – | – | 0.09% | 103 |
|
|
2024
Q2 | $623K | Sell |
6,722
-1,610
| -19% | -$149K | 0.09% | 107 |
|
|
2024
Q1 | $791K | Sell |
8,332
-2,601
| -24% | -$247K | 0.11% | 101 |
|
|
2023
Q4 | $976K | Sell |
10,933
-3,749
| -26% | -$335K | 0.13% | 74 |
|
|
2023
Q3 | $1.07M | Buy |
14,682
+6,210
| +73% | +$453K | 0.14% | 86 |
|
|
2023
Q2 | $705K | Buy |
8,472
+650
| +8% | +$54.1K | 0.09% | 96 |
|
|
2023
Q1 | $596K | Buy |
7,822
+5,400
| +223% | +$412K | 0.08% | 104 |
|
|
2022
Q4 | $201K | Buy |
+2,422
| New | +$201K | 0.03% | 167 |
|
|
2022
Q2 | – | Sell |
-150
| Closed | -$13K | – | 157 |
|
|
2022
Q1 | $13K | Buy |
150
+80
| +114% | +$6.93K | ﹤0.01% | 155 |
|
|
2021
Q4 | $8K | Buy |
+70
| New | +$8K | ﹤0.01% | 150 |
|